WA People
BILL · 2021–22 SESSION

HB 2091: Drug warehousing/B&O tax

Creating pathways to recovery from addiction by eliminating an obsolete tax preference for the warehousing of opioids and other drugs.

Summary

  • Increases the business and occupation (B&O) tax rate on businesses that warehouse and resell prescription drugs from 0.138 percent to 0.484 percent.
  • Directs the net difference in B&O tax collected from these businesses to the Recovery Pathways Account.

From the House Bill Analysis 2022 (HB 2091), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 25, 2022
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Lauren Davis (D-32)
Introduced
January 25, 2022 in the House
Last action
January 25, 2022
Companion bill
SB 5952
Budget
Has a fiscal note

AN ACT Relating to creating pathways to recovery from addiction by eliminating an obsolete tax preference for the warehousing of opioids and other drugs;

Sponsors

Prime sponsor: Lauren Davis (D-32)

7 co-sponsors (7 Democrats, 0 Republicans)

April Berg D-44Cindy Ryu D-32Sharon Tomiko Santos D-37Steve Bergquist D-11Alex Ramel D-40Shelley Kloba D-1Gerry Pollet D-46

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. First reading, referred to Finance.

HB 2091 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page